ACH
IMGN

ArrowMark Colorado Holdings’s Immunogen Inc IMGN Stock Holding History

ArrowMark Colorado Holdings’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200,780
Closed -$5.95M – 339
2023
Q4 		$5.95M Sell
200,780
-183,000
-48% -$3.64M 0.07% 194
2023
Q3 		$6.09M Buy
383,780
+219,288
+133% +$3.65M 0.07% 182
2023
Q2 		$3.1M Buy
+164,492
New +$1.94M 0.03% 217
2019
Q3 		– Sell
-1,046,376
Closed -$2.27M – 350
2019
Q2 		$2.27M Sell
1,046,376
-1,746,975
-63% -$4.13M 0.02% 239
2019
Q1 		$7.57M Sell
2,793,351
-813,373
-23% -$3.52M 0.07% 188
2018
Q4 		$17.3M Buy
3,606,724
+1,678,774
+87% +$10.2M 0.18% 116
2018
Q3 		$18.3M Buy
+1,927,950
New +$18.5M 0.15% 132

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ArrowMark Colorado Holdings's IMGN Position: Q1 2024 in Review

ArrowMark Colorado Holdings sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 200,780 shares — an estimated $5.95M sold.

ArrowMark Colorado Holdings first reported a position in IMGN in Q3 2018 and held it in 7 quarters. The position peaked at $18.3M in Q3 2018. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • ArrowMark Colorado Holdings reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 200,780 Immunogen Inc shares in Q1 2024, an estimated $5.95M.
  • ArrowMark Colorado Holdings first reported a position in Immunogen Inc in Q3 2018 and held it in 7 quarters.
  • ArrowMark Colorado Holdings's Immunogen Inc position peaked at $18.3M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2024, filed 15 May 2024.